Logo image of FROG

JFROG LTD (FROG) Stock Fundamental Analysis

USA - NASDAQ:FROG - IL0011684185 - Common Stock

47.86 USD
-1.5 (-3.04%)
Last: 9/16/2025, 8:24:22 PM
47.84 USD
-0.02 (-0.04%)
After Hours: 9/16/2025, 8:24:22 PM
Fundamental Rating

5

Overall FROG gets a fundamental rating of 5 out of 10. We evaluated FROG against 280 industry peers in the Software industry. FROG has a great financial health rating, but its profitability evaluates not so good. FROG is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FROG was profitable.
FROG had a positive operating cash flow in the past year.
In the past 5 years FROG always reported negative net income.
Each year in the past 5 years FROG had a positive operating cash flow.
FROG Yearly Net Income VS EBIT VS OCF VS FCFFROG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

FROG has a Return On Assets (-7.14%) which is comparable to the rest of the industry.
FROG has a Return On Equity (-10.44%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.14%
ROE -10.44%
ROIC N/A
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
FROG Yearly ROA, ROE, ROICFROG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

FROG has a better Gross Margin (75.53%) than 68.93% of its industry peers.
FROG's Gross Margin has been stable in the last couple of years.
FROG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
FROG Yearly Profit, Operating, Gross MarginsFROG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FROG has been increased compared to 1 year ago.
The number of shares outstanding for FROG has been increased compared to 5 years ago.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FROG Yearly Shares OutstandingFROG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FROG Yearly Total Debt VS Total AssetsFROG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

FROG has an Altman-Z score of 8.83. This indicates that FROG is financially healthy and has little risk of bankruptcy at the moment.
FROG's Altman-Z score of 8.83 is amongst the best of the industry. FROG outperforms 82.50% of its industry peers.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.83
ROIC/WACCN/A
WACC11%
FROG Yearly LT Debt VS Equity VS FCFFROG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.13 indicates that FROG has no problem at all paying its short term obligations.
FROG's Current ratio of 2.13 is fine compared to the rest of the industry. FROG outperforms 65.36% of its industry peers.
A Quick Ratio of 2.13 indicates that FROG has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.13, FROG is doing good in the industry, outperforming 66.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
FROG Yearly Current Assets VS Current LiabilitesFROG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.77% over the past year.
FROG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 178.78% yearly.
FROG shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.97%.
FROG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.56% yearly.
EPS 1Y (TTM)10.77%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)21.97%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%23.46%

3.2 Future

The Earnings Per Share is expected to grow by 18.80% on average over the next years. This is quite good.
Based on estimates for the next years, FROG will show a quite strong growth in Revenue. The Revenue will grow by 14.27% on average per year.
EPS Next Y9.67%
EPS Next 2Y13.13%
EPS Next 3Y18.8%
EPS Next 5YN/A
Revenue Next Year19.38%
Revenue Next 2Y17.63%
Revenue Next 3Y16.87%
Revenue Next 5Y14.27%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FROG Yearly Revenue VS EstimatesFROG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
FROG Yearly EPS VS EstimatesFROG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 66.47, FROG can be considered very expensive at the moment.
FROG's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.20, FROG is valued quite expensively.
A Price/Forward Earnings ratio of 57.53 indicates a quite expensive valuation of FROG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FROG is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of FROG to the average of the S&P500 Index (22.71), we can say FROG is valued expensively.
Industry RankSector Rank
PE 66.47
Fwd PE 57.53
FROG Price Earnings VS Forward Price EarningsFROG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of FROG indicates a somewhat cheap valuation: FROG is cheaper than 66.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 40.26
EV/EBITDA N/A
FROG Per share dataFROG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
FROG's earnings are expected to grow with 18.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.87
PEG (5Y)N/A
EPS Next 2Y13.13%
EPS Next 3Y18.8%

0

5. Dividend

5.1 Amount

No dividends for FROG!.
Industry RankSector Rank
Dividend Yield N/A

JFROG LTD

NASDAQ:FROG (9/16/2025, 8:24:22 PM)

After market: 47.84 -0.02 (-0.04%)

47.86

-1.5 (-3.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners77.46%
Inst Owner Change0.04%
Ins Owners13.41%
Ins Owner Change-4.91%
Market Cap5.59B
Analysts82.31
Price Target53.98 (12.79%)
Short Float %3.08%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.87%
Min EPS beat(2)8.08%
Max EPS beat(2)19.67%
EPS beat(4)4
Avg EPS beat(4)24.98%
Min EPS beat(4)8.08%
Max EPS beat(4)39.08%
EPS beat(8)8
Avg EPS beat(8)30.04%
EPS beat(12)12
Avg EPS beat(12)395.02%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.87%
Min Revenue beat(2)1.57%
Max Revenue beat(2)2.17%
Revenue beat(4)3
Avg Revenue beat(4)1.16%
Min Revenue beat(4)-0.34%
Max Revenue beat(4)2.17%
Revenue beat(8)4
Avg Revenue beat(8)0.45%
Revenue beat(12)4
Avg Revenue beat(12)-0.04%
Revenue beat(16)7
Avg Revenue beat(16)0.21%
PT rev (1m)15.84%
PT rev (3m)20.33%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)-2.6%
EPS NY rev (1m)0.82%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)1.21%
Revenue NY rev (3m)1.21%
Valuation
Industry RankSector Rank
PE 66.47
Fwd PE 57.53
P/S 11.77
P/FCF 40.26
P/OCF 39.45
P/B 6.76
P/tB 13.78
EV/EBITDA N/A
EPS(TTM)0.72
EY1.5%
EPS(NY)0.83
Fwd EY1.74%
FCF(TTM)1.19
FCFY2.48%
OCF(TTM)1.21
OCFY2.53%
SpS4.07
BVpS7.08
TBVpS3.47
PEG (NY)6.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.14%
ROE -10.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.53%
FCFM 29.23%
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 10.49%
Cap/Sales 0.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z 8.83
F-Score4
WACC11%
ROIC/WACCN/A
Cap/Depr(3y)19.73%
Cap/Depr(5y)42.11%
Cap/Sales(3y)0.98%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.77%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y9.67%
EPS Next 2Y13.13%
EPS Next 3Y18.8%
EPS Next 5YN/A
Revenue 1Y (TTM)21.97%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%23.46%
Revenue Next Year19.38%
Revenue Next 2Y17.63%
Revenue Next 3Y16.87%
Revenue Next 5Y14.27%
EBIT growth 1Y-47.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.24%
EBIT Next 3Y39%
EBIT Next 5YN/A
FCF growth 1Y460.55%
FCF growth 3Y67.17%
FCF growth 5Y67.4%
OCF growth 1Y405.3%
OCF growth 3Y58.42%
OCF growth 5Y61.81%